Literature DB >> 28777151

Does Strong and Diffuse PAX-8 Positivity Occur in Primary Lung Carcinoma? An Immunohistochemical Study of 418 Cases and Review of the Literature.

Kelsey E McHugh1, Andrea V Arrossi, Carol F Farver, Sanjay Mukhopadhyay.   

Abstract

Although rare cases of PAX-8-positive primary lung carcinoma have been reported, details of staining distribution and intensity in such cases are limited. The aim of this study was to determine whether strong and diffuse PAX-8 staining can occur in primary lung carcinoma. Immunohistochemical staining for PAX-8 (Rabbit polyclonal, 10336-1-AP; Proteintech) was performed on whole-tissue sections from 418 resected primary lung carcinomas. PAX-8 was positive in 5/418 (1.2%) cases, all of which were large cell neuroendocrine carcinomas. Staining was weak to moderate in all 5 cases, and was seen in 5% to 30% of tumor cells. All other primary lung carcinomas (413/418) were negative for PAX-8. This study-the largest series of PAX-8-stained whole-tissue sections of primary lung carcinoma to date-shows that strong and diffuse staining for PAX-8 does not occur in primary lung carcinoma of any type. This staining pattern in a carcinoma in a lung specimen provides strong evidence of nonpulmonary origin.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 28777151     DOI: 10.1097/PAI.0000000000000549

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  1 in total

1.  Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.

Authors:  Jianghua Wu; Yanhui Zhang; Tingting Ding; Runfen Cheng; Wenchen Gong; Yuhong Guo; Ye Luo; Yi Pan; Qiongli Zhai; Wei Sun; Dongmei Lin; Baocun Sun
Journal:  Endocr Pathol       Date:  2020-03       Impact factor: 3.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.